HLA-B*51:01 in Iranian patients with Behcet uveitis syndrome

被引:0
|
作者
Hoseini, Zahra [1 ]
Rad, Fatemeh Rezaei [1 ]
Zarei, Mohammad [2 ]
Ebrahimiadib, Nazanin [3 ]
Salimian, Zahra [1 ]
Zamani, Mahdi [1 ]
机构
[1] Univ Tehran Med Sci, Sch Med, Dept Med Genet, Tehran, Iran
[2] Univ Tehran Med Sci, Farabi Eye Hosp, Tehran, Iran
[3] Univ Florida, Dept Ophthalmol, Gainesville, FL USA
来源
REUMATOLOGIA CLINICA | 2024年 / 20卷 / 09期
关键词
Behcet's uveitis; HLA genes; PCR; DISEASE; HLA-B51; ASSOCIATION; MHC; SUSCEPTIBILITY; PATHOGENESIS; INSIGHTS;
D O I
10.1016/j.reuma.2024.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Behcet's disease (BD) is a multisystem disorder prevalent along the historic Silk Road, with Behcet's uveitis (BU) representing a significant complication contributing to disability. Various studies have linked different HLA alleles with BD across diverse populations. Methods: In this study, we investigated the association between HLA-B51:01/x and HLA-B27/x genotypes with Behcet's uveitis in 50 unrelated Iranian patients diagnosed with Behcet's uveitis, comparing them to a control group of 70 healthy individuals. Our analysis aimed to determine the susceptibility conferred by these alleles and assess their clinical relevance. Results: Our findings indicate a notable susceptibility conferred by the HLA-B51:01/x genotype for Behcet's uveitis (P = 0.0001). Conversely, the B27/x genotype did not demonstrate significant associations with Behcet's uveitis. Furthermore, we employed prevalence-corrected positive predictive value (PcPPV) calculations to gauge the clinical utility of testing for these alleles within the Iranian Behcet's uveitis patient population. The PcPPV for B27/x genotype testing was determined to be 0.05%, while the PcPPV for B51:01/x genotype testing in the same population was 0.065%. These results suggest that carriers of the B*51:01 allele, when presenting with clinical symptoms, exhibit a heightened risk for Behcet's uveitis compared to the general population. Conclusion: Individuals carrying the B51:01 allele, when symptomatic, face an elevated Behcet's uveitis risk. This insight aids in targeted clinical assessments for at-risk populations. (c) 2024 Published by Elsevier Espana, S.L.U.
引用
收藏
页码:470 / 475
页数:6
相关论文
共 50 条
  • [1] IDENTIFICATION OF THE HLA-B☆51:01 IMMUNOPEPTIDOME IN BEHCET'S DISEASE
    Lee, Y. J.
    Cho, K. C.
    Kim, S. H.
    Cho, B. K.
    Yi, E. C.
    Lee, E. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 455 - 456
  • [2] Lymphocyte proliferation induced by high-affinity peptides for HLA-B*51:01 in Behcet's uveitis
    Kaburaki, Toshikatsu
    Nakahara, Hisae
    Tanaka, Rie
    Okinaga, Kimiko
    Kawashima, Hidetoshi
    Hamasaki, Youichiro
    Rungrotmongkol, Thanyada
    Hannongbua, Supot
    Noguchi, Hiroshi
    Aihara, Makoto
    Takeuchi, Fujio
    PLOS ONE, 2019, 14 (09):
  • [3] HLA-B*51 and Behcet Disease
    Gul, Ahmet
    Ohno, Shigeaki
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2012, 20 (01) : 37 - 43
  • [4] Contribution of HLA-B*51:01 and -A*26:01 to Behcet's disease and their clinical association in Thai patients
    Louthrenoo, Worawit
    Kasitanon, Nuntana
    Pathanapitoon, Kessara
    Wangkaew, Suparaporn
    Kuwata, Shoji
    Nishi, Ai
    Kaburaki, Toshikatsu
    Tanaka, Rie
    Takeuchi, Fujio
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (02) : 247 - 255
  • [5] Epistatic Interaction of ERAP1 and HLA-B*51 in Iranian Patients with Behcet's Disease
    Mahmoudi, Mahdi
    Ashraf-Ganjouei, Amir
    Javinani, Ali
    Shahram, Farhad
    Meguro, Akira
    Mizuki, Nobuhisa
    Ahmadzadeh, Nooshin
    Jafarinejad-Farsangi, Saeideh
    Mostafaei, Shayan
    Kavosi, Hoda
    Faezi, Seyedeh Tahereh
    Akhlaghi, Maassoumeh
    Davatchi, Fereydoun
    SCIENTIFIC REPORTS, 2018, 8
  • [6] HLA class I genotyping including HLA-B*51 allele typing in the Iranian patients with Behcet's disease
    Mizuki, N
    Ota, M
    Katsuyama, Y
    Yabuki, K
    Ando, H
    Yoshida, M
    Onari, K
    Nikbin, B
    Davatchi, F
    Chams, H
    Ghaderi, AA
    Ohno, S
    Inoko, H
    TISSUE ANTIGENS, 2001, 57 (05): : 457 - 462
  • [7] Prognostic Impact of HLA-B*51 and HLA-A*26:01 On Ocular Behcet's Disease
    Park, Jun Won
    Kang, Eun Ha
    Kim, Hye Won
    Park, Chaerin
    Yu, Hyeong Gon
    Lee, Eun Young
    Lee, Yun Jong
    Lee, Eun Bong
    Song, Yeong Wook
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1004 - S1005
  • [8] Discovery of the novel HLA-B allele, HLA-B*51:01:01:36 in a Japanese individual
    Khor, Seik-Soon
    Hitomi, Yuki
    Omae, Yosuke
    Ogawa, Ayumi
    Tokunaga, Katsushi
    HLA, 2019, 94 (05) : 445 - +
  • [9] Genomic sequence of the HLA-B*08:01:71, HLA-B*51:382, and HLA-B*55:01:30 alleles
    Loginova, Maria
    Smirnova, Daria
    Paramonov, Igor
    HLA, 2023, 102 (05) : 621 - 622
  • [10] HLA-B☆51 the primary risk in Behcet disease
    Wallace, Graham R.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (24) : 8706 - 8707